Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_assertion type Assertion NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_head.
- NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_assertion wasGeneratedBy ECO_0000203 NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_provenance.
- NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_assertion wasDerivedFrom befree-20150227 NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_provenance.
- NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_assertion SIO_000772 21039418 NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_provenance.
- NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_assertion evidence source_evidence_literature NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_provenance.
- NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_assertion description "[Clinical results of osanetant and talnetant (selective-NK₃ antagonists) indicate that blocking the NK₃ receptor could be beneficial for the treatment of schizophrenia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965739.RASkTgfyMYXVF0yHhs6OoLKAHNLxfZ9di8GccURzF2AIk130_provenance.